-

Jamieson Wellness Inc. Reports Fourth Quarter and Full Year 2025 Results

Annual branded revenue growth of nearly 16% with broad‑based strength across all markets; Adjusted EBITDA growth outpaced revenue for the year

TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported financial results for its fourth quarter and full year ended December 31, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below.

Management Commentary

“2025 was an outstanding year for Jamieson Wellness, driven by sustained global demand for our products and superior execution across every key market,” said Mike Pilato, President and CEO. “Our branded business grew nearly 16%, with growth across each of our core geographies. Higher branded sales combined with investments in marketing and innovation expanded gross margins and drove double-digit growth in Adjusted EBITDA and cash flow.

“In China, we grew more than 56% in 2025 as our digital programs and performance marketing continued to deepen consumer engagement, and we're seeing that translate into material growth in brand health indicators and purchase conversion rates across all major platforms. Youtheory delivered double‑digit growth, with strong consumption across both digital and traditional channels driven by our new e‑commerce strategy and innovation in high-growth categories like stress and energy support.

“In Canada, our quality‑focused marketing campaign and strong innovation continue to resonate with consumers, driving category‑leading performance. Internationally, we delivered solid organic growth across our focus markets as demand remained healthy in key categories such as immunity, sleep, stress and energy.

“As we look to 2026, consumers continue to prioritize their health and wellness, and we're well-positioned to meet them – across geographies, across channels, and across life stages. We're focused on accelerating innovation, extending our reach in the markets that matter most, and strengthening our operational foundation as we continue to grow our branded platform on the path to $1 billion in revenue. I'm grateful to the entire Jamieson team for their commitment to our purpose of Inspiring Better Lives Every Day. Together, we are delivering innovative products for our consumers and building long-term value for our shareholders.”

Fiscal 2025 Highlights

  • Revenue growth in Canada outpaced the market, driven by consumer consumption behind the Company’s quality focused marketing campaign and strong on-trend innovation
  • Youtheory delivered double-digit revenue growth vs prior year, driven by strong e-commerce consumption, innovation, and new distribution
  • Revenue in China outpaced the market by 4x, driven by material increases in brand awareness, trial, and consumer conversion to regular buyers
  • Growth continued in International markets, particularly in core markets in the Middle East, Europe, and the Caribbean, driven by strong local innovation and the Company’s Canadian quality marketing campaign, launched globally
  • Operating cash flows before working capital considerations grew 23.2% vs prior year, driven by higher earnings, increased operating leverage and strategic pacing of SG&A investments
  • Successfully implemented new ERP system in Q1 of 2025, modernizing the Company’s data management and digital capabilities to deliver next phase of long-term growth

Summary of Fourth Quarter Consolidated Results

All comparisons are with the fourth quarter of 2024

  • Consolidated revenue increased 13.4% to $277.7 million, driven by 17.1% growth in Jamieson Brands, partially offset by an expected decline in Strategic Partners revenue
  • Gross profit increased by $18.5 million to $118.7 million, mainly driven by higher Jamieson Brands revenues and increased margins
  • Gross profit margin3 increased by 180 basis points due to a higher proportion of growth in Jamieson Brands sales
  • EBITDA1 increased by $0.4 million to $64.3 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA1 increased by $8.1 million, reflecting the impact of higher sales volumes, partially offset by investments in SG&A
  • Net earnings was $37.6 million; Adjusted net earnings1 was $38.5 million, or $3.9 million higher, reflecting higher normalized earnings from operations
  • Diluted earnings per share was $0.86; Adjusted diluted earnings per share2 was $0.90

Summary of Fourth Quarter Segment Results

All comparisons are with the fourth quarter of 2024

Jamieson Brands

  • Revenue increased 17.1% or $34.7 million to $237.4 million
    • Canada increased by 5.5%, largely reflecting strong consumer consumption driven by quality-focused marketing campaigns and innovations
    • Youtheory increased by 20.2%, mainly driven by innovation and continued strong consumption in e-commerce and growth in traditional channels
    • China increased by 43.9%, primarily driven by successful performance marketing campaigns and innovations generating growth and brand loyalty across all major digital platforms
    • International increased by 39.2%, reflecting strong consumption and organic growth from all major markets, led by the Middle East.
  • Gross profit increased $18.6 million to $113.0 million; normalized gross profit increased by $18.3 million
  • Gross profit margin3 increased by 100 bps; normalized gross profit margin increased by 90 bps to 47.6% mainly driven by higher volumes in China, the Company’s highest gross margin business
  • Adjusted EBITDA1 increased $8.6 million to $62.9 million driven by higher gross profit and partially offset by SG&A due to performance marketing campaigns in China; Adjusted EBITDA margin2 decreased by 30 bps to 26.5%, consistent with prior year while slightly impacted by timing of variable compensation in SG&A in the prior year

Strategic Partners

All comparisons are with the fourth quarter of 2024

  • Revenue decreased by an expected 4.4% to $40.3 million, impacted by a reduction in business and the timing of onboarding new customer contracts amidst trade and tariff uncertainties
  • Gross profit was $5.7 million, a decrease of $0.1 million; gross profit margin3 was 14.1%, an increase of 30 bps, impacted by customer and product mix
  • Adjusted EBITDA1 was $4.7 million representing an Adjusted EBITDA margin2 of 11.6%, lower by 50 bps

Summary of Fourth Quarter Balance Sheet and Cash Flow from Operations

All comparisons are with the fourth quarter of 2024

  • As at December 31, 2025, the Company had approximately $126.6 million in cash and available revolving and swingline facilities and net debt1 of $373.4 million
  • The Company generated $31.9 million in cash from operations compared to $37.8 million generated in Q4 2024
  • Cash from operating activities before working capital considerations was $12.9 million higher than Q4 2024
  • Cash invested in working capital increased by $18.8 million mainly due to increased inventories to support the growth of the business and securing supply amidst tariff uncertainties and port congestion
  • During the three-month period ended December 31, 2025, the Company purchased 532,780 common shares for cancellation under its NCIB program for an aggregate consideration of $18.1 million

Summary of Fiscal 2025 Consolidated Results

All comparisons are with the fiscal year ended December 31, 2024

  • Consolidated revenue increased 12.0% to $822.1 million driven by 15.6% growth in Jamieson Brands revenue, partially offset by a 9.1% decline in Strategic Partners revenue, which was impacted by reductions in customer specific programs and timing of onboarding new customer contracts amidst trade and tariff uncertainties
  • Adjusted EBITDA1 increased by $18.7 million or 13.3% to $159.7 million
  • Net earnings were $64.5 million; Adjusted net earnings increased 15.0% to $79.4 million
  • Diluted earnings per share was $1.46; Adjusted diluted earnings per share2 was $1.85

1 This is a non-IFRS financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS financial measure.

2 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.

3 This is a supplementary financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each supplementary financial measure.

Fiscal 2026 Outlook

All comparisons are with the fiscal year ended December 31, 2025

In fiscal 2026 the Company expects:

  • Consolidated revenue of between $895.0 million and $935.0 million, representing growth of 9.0% to 13.7%
  • Jamieson Brands revenue of $790.0 million to $820.0 million, or growth of between 8.7% and 12.9%. Beginning Q1 2026, youtheory branded revenue is allocated to its respective geographic business unit, rather than consolidated under youtheory (U.S.) as previously disclosed.
    • China: building on strong 2025 momentum and a significantly scaled consumer base, revenue is expected to grow between 20.0% and 30.0%, driven by continued strong marketing programs, innovation, and distribution gains
    • U.S.: revenue is expected to grow between 14.0% and 19.0% in USD, reflecting continued digital marketing and sales expansion, innovation, and distribution gains
    • Canada: revenue growth between 4.0% and 6.0%, led by continued market leading quality marketing campaign, innovation, and digital growth
    • International: revenue growth between 10.0% and 15.0% in contracted base currency, primarily the US dollar, led by locally relevant innovation and distribution gains in key markets such as the Middle East and Eastern Europe
  • Strategic Partners revenue growth between 10.0% and 20.0%, driven by the full year impact of new programs and new customers
  • Consolidated Adjusted EBITDA between $174.0 and $181.0 million, or growth of 9.0% to 13.4%
  • Consolidated Adjusted EBITDA margins to be maintained at approximately 19.4%, reflecting ongoing margin expansion in each branded business segment offset by geographical mix
  • Adjusted diluted earnings per share of $2.08 to $2.21, or growth of 12.5% to 19.5%

The Company’s 2026 guidance reflects the current prevailing trade environment between the United States, Canada and other countries. To date, tariffs have not had a material impact on the Company’s overall financial performance, as most of these costs have been mitigated through flexible supply chain and operating efficiencies. The Company recognizes the trade environment is constantly changing, including upcoming USMCA negotiations which may introduce changes to cross-border trade requirements and associated costs. As a result, actual results may be impacted by future changes in global trade policies. For additional details on the Company’s fiscal 2026 outlook, including guidance for the first quarter of 2026, refer to the “Outlook” section in the management’s discussion and analysis of financial condition and results of operations (“MD&A”) for the three and twelve months ended December 31, 2025. The Company’s 2026 guidance is based on a number of key assumptions set forth in the section titled “Outlook – Key Assumptions” in the MD&A, which section is incorporated by reference into this press release.

Fourth Quarter Dividend

On February 26, 2026, the Company announced that the board of directors declared a cash dividend for the fourth quarter of 2025:

  • $0.23 per common share or approximately $9.5 million in total
  • Paid on March 16, 2026 to all common shareholders of record at the close of business on March 6, 2026
  • The Company has designated this dividend as an “eligible dividend” for the purposes of the Income Tax Act (Canada)

Consolidated Financial Statements and Management’s Discussion and Analysis

The Company’s audited consolidated annual financial statements and accompanying notes as at and for the three and twelve months ended December 31, 2025 and related 2025 MD&A are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com.

Conference Call

Management will host a conference call to discuss the Company’s fourth quarter and full year 2025 results at 5:00 p.m. ET today, February 26, 2026. To access:

About Jamieson Wellness

Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit www.jamiesonwellness.com.

Jamieson Wellness’ head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and its outlook for its 2026 revenue, Adjusted EBITDA, Adjusted EBITDA margins and Adjusted diluted earnings per share. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances, which could prove to be incorrect.

The forward-looking information in this press release is based on a number of assumptions, including our ability to pursue further strategic acquisitions; our ability to source raw materials and other inputs from our suppliers; our ability to continue to innovate product offerings that resonate with our target customer base; our ability to retain key management and personnel; our ability to continue to expand our international presence and grow our brand internationally; our ability to obtain and maintain existing financing on acceptable terms; currency exchange and interest rates; the impact of competition; changes to trends in our industry or global economic factors; and changes to laws, rules, regulations and global standards . The forward-looking information in this press release is also subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2025 and under the “Risk Factors” section in the 2025 MD&A filed today, February 26, 2026. The Company cautions that the forgoing list of assumptions and risks is not exhaustive and other factors could also adversely affect the Company’s results.

The forward-looking information in this press release is given as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Jamieson Wellness Inc.

Selected Consolidated Financial Information

In thousands of Canadian dollars, except share and per share amounts

 
Three months ended Twelve months ended
December 31 December 31

2025

2024

2025

2024

 
Revenue

277,659

 

244,781

 

822,056

 

733,780

 

Cost of sales

158,976

 

144,555

 

483,724

 

458,170

 

Gross profit

118,683

 

100,226

 

338,332

 

275,610

 

 
Gross profit margin

42.7

%

40.9

%

41.2

%

37.6

%

 
Selling, general and administrative expenses

58,890

 

49,082

 

216,164

 

174,489

 

Acquisition related adjustments

(3,766

)

(12,425

)

(3,766

)

(12,425

)

Share-based compensation

2,125

 

1,987

 

8,408

 

7,268

 

Earnings from operations

61,434

 

61,582

 

117,526

 

106,278

 

 
Operating margin

22.1

%

25.2

%

14.3

%

14.5

%

 
Foreign exchange loss

2,163

 

1,852

 

1,853

 

1,479

 

Interest expense and other financing costs

6,401

 

5,684

 

22,409

 

20,272

 

Accretion on preferred shares

-

 

2,220

 

3,427

 

8,729

 

Earnings before income taxes

52,870

 

51,826

 

89,837

 

75,798

 

Provision for income taxes

15,233

 

15,705

 

25,373

 

24,665

 

Net earnings

37,637

 

36,121

 

64,464

 

51,133

 

 
Net earnings attributable to:
Shareholders

36,833

 

36,810

 

62,437

 

51,914

 

Non-controlling interests

804

 

(689

)

2,027

 

(781

)

37,637

 

36,121

 

64,464

 

51,133

 

Adjusted net earnings

38,500

 

34,641

 

79,394

 

69,044

 

 
EBITDA

64,320

 

63,890

 

135,330

 

123,331

 

Adjusted EBITDA

67,571

 

59,437

 

159,706

 

141,003

 

 
Adjusted EBITDA margin

24.3

%

24.3

%

19.4

%

19.2

%

 
Weighted average number of shares
Basic

41,825,723

 

41,818,220

 

41,833,795

 

41,580,983

 

Diluted

42,919,362

 

43,179,260

 

42,882,406

 

42,843,210

 

 
Earnings per share attributable to common shareholders:
Basic, earnings per share

0.88

 

0.86

 

1.49

 

1.23

 

Diluted, earnings per share

0.86

 

0.84

 

1.46

 

1.19

 

Adjusted diluted, earnings per share

0.90

 

0.80

 

1.85

 

1.61

 

Jamieson Wellness Inc.

Consolidated Statements of Financial Position

In thousands of Canadian dollars

 

December 31,

December 31,

2025

2024

Assets
Current assets
Cash

41,225

44,787

Accounts receivable

199,245

228,031

Inventories

203,083

154,658

Derivatives

486

2,661

Prepaid expenses and other current assets

7,303

6,803

451,342

436,940

Non-current assets
Property, plant and equipment

117,342

103,591

Goodwill

279,644

287,503

Intangible assets

362,753

377,214

Deferred income tax

3,951

3,545

Total assets

1,215,032

1,208,793

 
Liabilities
Current liabilities
Accounts payable and accrued liabilities

155,266

137,653

Income taxes payable

2,894

4,373

Derivatives

3,971

2,982

Current portion of other long-term liabilities

12,014

27,673

174,145

172,681

Long-term liabilities
Long-term debt

414,597

308,285

Post-retirement benefits

1,282

1,209

Deferred income tax

68,855

64,467

Redeemable preferred shares

-

98,138

Other long-term liabilities

26,642

15,633

Total liabilities

685,521

660,413

 
Equity
Share capital

333,347

326,219

Warrants

14,705

14,705

Contributed surplus

27,494

23,835

Retained earnings

90,374

99,109

Accumulated other comprehensive income

19,498

41,313

Total shareholders' equity

485,418

505,181

Non-controlling interests

44,093

43,199

Total equity

529,511

548,380

Total liabilities and equity

1,215,032

1,208,793

Non-IFRS and Other Financial Measures

This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses the following non-IFRS financial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, “normalized gross profit”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross profit margin”, “normalized operating margin”, and the following supplementary financial measures: “gross profit margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company’s financial statements to which the measure relates.

The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the “Non-IFRS and Other Financial Measures” of this press release for further information on each non-IFRS financial measure) for the three and twelve months ended December 31, 2025.

Jamieson Wellness Inc.

Segment Information

In thousands of Canadian dollars, except as otherwise noted

 
Jamieson Brands
 
Three months ended
December 31

2025

2024

$ Change

% Change

 
Revenue

237,361

 

202,621

 

34,740

 

17.1

%

 
Gross profit

112,992

 

94,395

 

18,597

 

19.7

%

Labour relations costs (1)

-

 

315

 

(315

)

(100.0

%)

Normalized gross profit

112,992

 

94,710

 

18,282

 

19.3

%

 
Gross profit margin

47.6

%

46.6

%

-

 

1.0

%

Normalized gross profit margin

47.6

%

46.7

%

-

 

0.9

%

 
Share-based compensation (2)

2,125

 

1,987

 

138

 

6.9

%

 
Selling, general and administrative expenses

57,187

 

47,621

 

9,566

 

20.1

%

Labour relations costs (1)

-

 

(462

)

462

 

100.0

%

IT system implementation (3)

(799

)

(2,141

)

1,342

 

62.7

%

Due diligence, legal, and other (4)

(1,930

)

(1,215

)

(715

)

(58.8

%)

Normalized selling, general and administrative expenses

54,458

 

43,803

 

10,655

 

24.3

%

 
Earnings from operations

57,446

 

57,212

 

234

 

0.4

%

Labour relations costs (1)

-

 

777

 

(777

)

(100.0

%)

IT system implementation (3)

799

 

2,141

 

(1,342

)

(62.7

%)

Acquisition related purchase consideration adjustments (5)

(3,766

)

(12,425

)

8,659

 

69.7

%

Due diligence, legal, and other (4)

1,930

 

1,215

 

715

 

58.8

%

Normalized earnings from operations

56,409

 

48,920

 

7,489

 

15.3

%

 
Operating margin

24.2

%

28.2

%

-

 

(4.0

%)

Normalized operating margin

23.8

%

24.1

%

-

 

(0.3

%)

 
Adjusted EBITDA

62,908

 

54,341

 

8,567

 

15.8

%

Adjusted EBITDA margin

26.5

%

26.8

%

-

 

(0.3

%)

Strategic Partners
 
Three months ended
December 31

2025

2024

$ Change

% Change

 
Revenue

40,298

 

42,160

 

(1,862

)

(4.4

%)

 
Gross profit

5,691

 

5,831

 

(140

)

(2.4

%)

Gross profit margin

14.1

%

13.8

%

-

 

0.3

%

 
Selling, general and administrative expenses

1,703

 

1,461

 

242

 

16.6

%

 
Earnings from operations

3,988

 

4,370

 

(382

)

(8.7

%)

 
Operating margin

9.9

%

10.4

%

-

 

(0.5

%)

 
Adjusted EBITDA

4,663

 

5,096

 

(433

)

(8.5

%)

Adjusted EBITDA margin

11.6

%

12.1

%

-

 

(0.5

%)

Jamieson Wellness Inc.

Segment Information (continued)

In thousands of Canadian dollars, except as otherwise noted

 
Jamieson Brands
 
Twelve months ended
December 31

2025

2024

$ Change

% Change

 
Revenue

726,582

 

628,744

 

97,838

 

15.6

%

 
Gross profit

326,286

 

262,065

 

64,221

 

24.5

%

Labour relations costs (1)

-

 

5,028

 

(5,028

)

(100.0

%)

IT system implementation (3)

1,023

 

-

 

1,023

 

100.0

%

Due diligence, legal, and other (4)

-

 

165

 

(165

)

(100.0

%)

Normalized gross profit

327,309

 

267,258

 

60,051

 

22.5

%

 
Gross profit margin

44.9

%

41.7

%

-

 

3.2

%

Normalized gross profit margin

45.0

%

42.5

%

-

 

2.5

%

 
Share-based compensation (2)

8,408

 

7,268

 

1,140

 

15.7

%

 
Selling, general and administrative expenses

209,809

 

168,459

 

41,350

 

24.5

%

IT system implementation (3)

(10,244

)

(11,562

)

1,318

 

11.4

%

Labour relations costs (1)

-

 

(2,137

)

2,137

 

100.0

%

Donations (6)

(3,118

)

-

 

(3,118

)

(100.0

%)

Due diligence, legal, and other (4)

(3,270

)

(2,458

)

(812

)

(33.0

%)

Normalized selling, general and administrative expenses

193,177

 

152,302

 

40,875

 

26.8

%

 
Earnings from operations

111,835

 

98,763

 

13,072

 

13.2

%

IT system implementation (3)

11,267

 

11,562

 

(295

)

(2.6

%)

Labour relations costs (1)

-

 

7,165

 

(7,165

)

(100.0

%)

Donations (6)

3,118

 

-

 

3,118

 

100.0

%

Acquisition related purchase consideration and post-closing adjustments (5)

(3,766

)

(12,425

)

8,659

 

69.7

%

Due diligence, legal, and other (4)

3,270

 

2,623

 

647

 

24.7

%

Normalized earnings from operations

125,724

 

107,688

 

18,036

 

16.7

%

 
Operating margin

15.4

%

15.7

%

-

 

(0.3

%)

Normalized operating margin

17.3

%

17.1

%

-

 

0.2

%

 
Adjusted EBITDA

151,105

 

130,496

 

20,609

 

15.8

%

Adjusted EBITDA margin

20.8

%

20.8

%

-

 

-

 

Strategic Partners
 
Twelve months ended
December 31

2025

2024

$ Change

% Change

 
Revenue

95,474

 

105,036

 

(9,562

)

(9.1

%)

 
Gross profit

12,046

 

13,545

 

(1,499

)

(11.1

%)

IT system implementation (3)

226

 

-

 

226

 

100.0

%

Normalized gross profit

12,272

 

13,545

 

(1,273

)

(9.4

%)

 
Gross profit margin

12.6

%

12.9

%

-

 

(0.3

%)

Normalized gross profit margin

12.9

%

12.9

%

-

 

-

 

 
Selling, general and administrative expenses

6,355

 

6,030

 

325

 

5.4

%

 
Earnings from operations

5,691

 

7,515

 

(1,824

)

(24.3

%)

IT system implementation (3)

226

 

-

 

226

 

100.0

%

Normalized earnings from operations

5,917

 

7,515

 

(1,598

)

(21.3

%)

 
Operating margin

6.0

%

7.2

%

-

 

(1.2

%)

Normalized operating margin

6.2

%

7.2

%

-

 

(1.0

%)

 
Adjusted EBITDA

8,601

 

10,507

 

(1,906

)

(18.1

%)

Adjusted EBITDA margin

9.0

%

10.0

%

-

 

(1.0

%)

Reconciliation of Non-IFRS Financial Measures

In thousands of Canadian dollars

 
Three months ended Twelve months ended
December 31 December 31

2025

2024

2025

2024

 
 
Net earnings:

37,637

 

36,121

 

64,464

 

51,133

 

Add:
Recovery of income taxes

15,233

 

15,705

 

25,373

 

24,665

 

Interest expense and other financing costs

6,401

 

5,684

 

22,409

 

20,272

 

Accretion on preferred shares

-

 

2,220

 

3,427

 

8,729

 

Depreciation of property, plant, and equipment

3,431

 

2,635

 

13,579

 

12,588

 

Amortization of intangible assets

1,618

 

1,525

 

6,078

 

5,944

 

 
Earnings before interest, taxes, depreciation, and amortization (EBITDA)

64,320

 

63,890

 

135,330

 

123,331

 

Share-based compensation (2)

2,125

 

1,987

 

8,408

 

7,268

 

Foreign exchange loss

2,163

 

1,852

 

1,853

 

1,479

 

Labour relations costs (1)

-

 

777

 

-

 

7,165

 

IT system implementation (3)

799

 

2,141

 

11,493

 

11,562

 

Acquisition related purchase consideration and post-closing adjustments (5)

(3,766

)

(12,425

)

(3,766

)

(12,425

)

Donations (6)

-

 

-

 

3,118

 

-

 

Due diligence, legal, and other (4)

1,930

 

1,215

 

3,270

 

2,623

 

Adjusted EBITDA

67,571

 

59,437

 

159,706

 

141,003

 

 
Recovery of income taxes

(15,233

)

(15,705

)

(25,373

)

(24,665

)

Interest expense and other financing costs

(6,401

)

(5,684

)

(22,409

)

(20,272

)

Depreciation of property, plant, and equipment

(3,431

)

(2,635

)

(13,579

)

(12,588

)

Amortization of intangible assets

(1,618

)

(1,525

)

(6,078

)

(5,944

)

Share-based compensation (2)

(2,003

)

(1,865

)

(7,920

)

(6,780

)

Tax deduction from vesting of certain share-based awards

-

 

-

 

(708

)

-

 

Tax effect of normalization adjustments

(385

)

2,618

 

(4,245

)

(1,710

)

Adjusted net earnings

38,500

 

34,641

 

79,394

 

69,044

 

Three months ended Twelve months ended
December 31 December 31

2025

2024

2025

2024

 
Gross profit

118,683

 

100,226

 

338,332

 

275,610

 

Labour relations costs (1)

-

 

315

 

-

 

5,028

 

Due diligence, legal, and other (4)

-

 

-

 

-

 

165

 

IT system implementation (3)

-

 

-

 

1,249

 

-

 

Normalized gross profit

118,683

 

100,541

 

339,581

 

280,803

 

Normalized gross profit margin

42.7

%

41.1

%

41.3

%

38.3

%

 
Selling, general and administrative expenses

58,890

 

49,082

 

216,164

 

174,489

 

IT system implementation (3)

(799

)

(2,141

)

(10,244

)

(11,562

)

Labour relations costs (1)

-

 

(462

)

-

 

(2,137

)

Donations (6)

-

 

-

 

(3,118

)

-

 

Due diligence, legal, and other (4)

(1,930

)

(1,215

)

(3,270

)

(2,458

)

Normalized selling, general and administrative expenses

56,161

 

45,264

 

199,532

 

158,332

 

 
Earnings from operations

61,434

 

61,582

 

117,526

 

106,278

 

Acquisition related purchase consideration and post-closing adjustments (5)

(3,766

)

(12,425

)

(3,766

)

(12,425

)

IT system implementation (3)

799

 

2,141

 

11,493

 

11,562

 

Donations (6)

-

 

-

 

3,118

 

-

 

Labour relations costs (1)

-

 

777

 

-

 

7,165

 

Due diligence, legal, and other (4)

1,930

 

1,215

 

3,270

 

2,623

 

Normalized earnings from operations

60,397

 

53,290

 

131,641

 

115,203

 

Normalized operating margin

21.8

%

21.8

%

16.0

%

15.7

%

(1)

These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer fines and penalties, along with freight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024.

 

(2)

Our share-based compensation expense pertains to our long-term incentive plan (the “LTIP”), with stock options, performance-based share units (“PSUs”), time-based restricted share units (“RSUs”), and deferred share units (“DSUs”) expenses, along with associated payroll taxes.

 

(3)

Mainly pertains to development and post implementation start-up costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.

 

(4)

Includes professional service fees relating to completed due diligence costs for an unsuccessful acquisition and other non-recurring expenses primarily relating to non-operational legal costs.

 

(5)

To adjust for the fair value of purchase consideration accounted for as compensation in the 2022 youtheory acquisition, net of post-acquisition working capital adjustments to reflect acquired liabilities.

 

(6)

Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires.

Reconciliation of Net Debt

In thousands of Canadian dollars

 
($ in 000's)

As at December 31,

As at December 31,

2025

2024

 
Long-term debt

414,597

 

308,285

 

Cash

(41,225

)

(44,787

)

Net debt

373,372

 

263,498

 

 

Contacts

Investor Relations and Media Contact Information:
Jamieson Wellness
Ruth Winker
416-960-0052
rwinker@jamiesonlabs.com

Jamieson Wellness Inc.

TSX:JWEL

Release Versions

Contacts

Investor Relations and Media Contact Information:
Jamieson Wellness
Ruth Winker
416-960-0052
rwinker@jamiesonlabs.com

More News From Jamieson Wellness Inc.

Jamieson Wellness Inc. Announces Renewal of Normal Course Issuer Bid

TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) for the repurchase of common shares as appropriate opportunities arise from time to time in accordance with the requirements of the TSX. Pursuant to the NCIB, the Company may purchase for cancellation up to 3,444,429 common shares of the Company, which repre...

Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call

TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its fourth quarter and full year 2025 financial results after the market close on Thursday, February 26, 2026. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the fourth quarter and full year 2025 results. The call can be accessed live over the telephone by dialing 1-800-717-1738 from Canada and the U.S. or 1-...

Jamieson Wellness Inc. Reports Third Quarter 2025 Results

TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below. Management Commentary “In Q3, Jamieson delivered another strong quarter with 16.5% branded growth and momentum...
Back to Newsroom